Used as a key intermediate in the synthesis of omeprazole and related proton pump inhibitors, which are widely prescribed for treating gastric acid-related disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. Its structure enables selective reactivity in forming benzimidazole-based pharmaceuticals. Also employed in research for developing new bioactive molecules with potential antimicrobial and anti-inflammatory properties.